139 related articles for article (PubMed ID: 15940254)
1. Gene expression profiles in cells transformed by overexpression of the IGF-I receptor.
Loughran G; Huigsloot M; Kiely PA; Smith LM; Floyd S; Ayllon V; O'Connor R
Oncogene; 2005 Sep; 24(40):6185-93. PubMed ID: 15940254
[TBL] [Abstract][Full Text] [Related]
2. beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
Goel HL; Breen M; Zhang J; Das I; Aznavoorian-Cheshire S; Greenberg NM; Elgavish A; Languino LR
Cancer Res; 2005 Aug; 65(15):6692-700. PubMed ID: 16061650
[TBL] [Abstract][Full Text] [Related]
3. The insulin-like growth factor I receptor is required for Akt activation and suppression of anoikis in cells transformed by the ETV6-NTRK3 chimeric tyrosine kinase.
Martin MJ; Melnyk N; Pollard M; Bowden M; Leong H; Podor TJ; Gleave M; Sorensen PH
Mol Cell Biol; 2006 Mar; 26(5):1754-69. PubMed ID: 16478996
[TBL] [Abstract][Full Text] [Related]
4. Filamin A is a novel caveolin-1-dependent target in IGF-I-stimulated cancer cell migration.
Ravid D; Chuderland D; Landsman L; Lavie Y; Reich R; Liscovitch M
Exp Cell Res; 2008 Sep; 314(15):2762-73. PubMed ID: 18598695
[TBL] [Abstract][Full Text] [Related]
5. Promotion of colorectal cancer growth and metastasis by the LIM and SH3 domain protein 1.
Zhao L; Wang H; Liu C; Liu Y; Wang X; Wang S; Sun X; Li J; Deng Y; Jiang Y; Ding Y
Gut; 2010 Sep; 59(9):1226-35. PubMed ID: 20660701
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype.
Pennisi PA; Barr V; Nunez NP; Stannard B; Le Roith D
Cancer Res; 2002 Nov; 62(22):6529-37. PubMed ID: 12438247
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel primary mammary tumor cell line reveals that cyclin D1 is regulated by the type I insulin-like growth factor receptor.
Jones RA; Campbell CI; Petrik JJ; Moorehead RA
Mol Cancer Res; 2008 May; 6(5):819-28. PubMed ID: 18505926
[TBL] [Abstract][Full Text] [Related]
8. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
[TBL] [Abstract][Full Text] [Related]
9. Effect of the insulin-like growth factor I receptor on ionizing radiation-induced cell death in mouse embryo fibroblasts.
Nakamura S; Watanabe H; Miura M; Sasaki T
Exp Cell Res; 1997 Aug; 235(1):287-94. PubMed ID: 9281378
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro.
Sekharam M; Nasir A; Kaiser HE; Coppola D
Anticancer Res; 2003; 23(2B):1517-24. PubMed ID: 12820418
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway.
Sekharam M; Zhao H; Sun M; Fang Q; Zhang Q; Yuan Z; Dan HC; Boulware D; Cheng JQ; Coppola D
Cancer Res; 2003 Nov; 63(22):7708-16. PubMed ID: 14633695
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin.
Adachi Y; Li R; Yamamoto H; Min Y; Piao W; Wang Y; Imsumran A; Li H; Arimura Y; Lee CT; Imai K; Carbone DP; Shinomura Y
Carcinogenesis; 2009 Aug; 30(8):1305-13. PubMed ID: 19493905
[TBL] [Abstract][Full Text] [Related]
13. [shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments].
Dong AQ; Kong MJ; Ma ZY; Qian JF; Fan JQ; Xu XH
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1506-9. PubMed ID: 17785094
[TBL] [Abstract][Full Text] [Related]
14. The adapter protein Grb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts.
Laviola L; Giorgino F; Chow JC; Baquero JA; Hansen H; Ooi J; Zhu J; Riedel H; Smith RJ
J Clin Invest; 1997 Mar; 99(5):830-7. PubMed ID: 9062339
[TBL] [Abstract][Full Text] [Related]
15. The role of Grb2 in the growth and transformation of mouse embryo cells.
D'Ambrosio C; Hongo A; Li S; Baserga R
Oncogene; 1996 Jan; 12(2):371-8. PubMed ID: 8570214
[TBL] [Abstract][Full Text] [Related]
16. Interaction of IGF signaling and the androgen receptor in prostate cancer progression.
Wu JD; Haugk K; Woodke L; Nelson P; Coleman I; Plymate SR
J Cell Biochem; 2006 Oct; 99(2):392-401. PubMed ID: 16639715
[TBL] [Abstract][Full Text] [Related]
17. IGF-1 upregulates electroneutral K-Cl cotransporter KCC3 and KCC4 which are differentially required for breast cancer cell proliferation and invasiveness.
Hsu YM; Chou CY; Chen HH; Lee WY; Chen YF; Lin PW; Alper SL; Ellory JC; Shen MR
J Cell Physiol; 2007 Mar; 210(3):626-36. PubMed ID: 17133354
[TBL] [Abstract][Full Text] [Related]
18. Regulation of the Mr 72,000 type IV collagenase by the type I insulin-like growth factor receptor.
Long L; Navab R; Brodt P
Cancer Res; 1998 Aug; 58(15):3243-7. PubMed ID: 9699649
[TBL] [Abstract][Full Text] [Related]
19. The receptor for the type I insulin-like growth factor and its ligands regulate multiple cellular functions that impact on metastasis.
Samani AA; Brodt P
Surg Oncol Clin N Am; 2001 Apr; 10(2):289-312, viii. PubMed ID: 11382588
[TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]